Rohto Pharmaceutical Co.,Ltd. (4527.T)
JPY 2319.0
(-1.17%)
JPY 2319.0
(-1.17%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 30.93 Billion JPY | 17.28% |
| 2022 | 26.37 Billion JPY | 24.85% |
| 2021 | 21.12 Billion JPY | 26.18% |
| 2020 | 16.74 Billion JPY | 8.65% |
| 2019 | 15.41 Billion JPY | 57.26% |
| 2018 | 9.79 Billion JPY | 5.49% |
| 2017 | 9.28 Billion JPY | -7.21% |
| 2016 | 10.01 Billion JPY | 10.04% |
| 2015 | 9.09 Billion JPY | 5.41% |
| 2014 | 8.63 Billion JPY | -3.53% |
| 2013 | 8.94 Billion JPY | 10.63% |
| 2012 | 8.08 Billion JPY | -1.19% |
| 2011 | 8.18 Billion JPY | 2.74% |
| 2010 | 7.96 Billion JPY | 2.55% |
| 2009 | 7.76 Billion JPY | 26.54% |
| 2008 | 6.13 Billion JPY | -18.42% |
| 2007 | 7.52 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 8.48 Billion JPY | 77.48% |
| 2023 Q4 | 4.77 Billion JPY | -50.03% |
| 2023 FY | 30.93 Billion JPY | 17.28% |
| 2023 Q1 | 9.09 Billion JPY | 91.77% |
| 2023 Q2 | 7.5 Billion JPY | -17.45% |
| 2023 Q3 | 9.56 Billion JPY | 27.44% |
| 2022 Q1 | 6.99 Billion JPY | 71.21% |
| 2022 Q4 | 4.74 Billion JPY | -43.87% |
| 2022 Q3 | 8.44 Billion JPY | 36.25% |
| 2022 FY | 26.37 Billion JPY | 24.85% |
| 2022 Q2 | 6.19 Billion JPY | -11.38% |
| 2021 Q2 | 6.02 Billion JPY | 27.35% |
| 2021 Q4 | 4.08 Billion JPY | -33.87% |
| 2021 Q3 | 6.17 Billion JPY | 2.52% |
| 2021 FY | 21.12 Billion JPY | 26.18% |
| 2021 Q1 | 4.73 Billion JPY | -16.41% |
| 2020 FY | 16.74 Billion JPY | 8.65% |
| 2020 Q1 | 1.93 Billion JPY | -31.99% |
| 2020 Q3 | 4.9 Billion JPY | 15.66% |
| 2020 Q2 | 4.24 Billion JPY | 118.95% |
| 2020 Q4 | 5.66 Billion JPY | 15.39% |
| 2019 Q2 | 5.08 Billion JPY | 129.5% |
| 2019 Q4 | 2.84 Billion JPY | -45.82% |
| 2019 FY | 15.41 Billion JPY | 57.26% |
| 2019 Q1 | 2.21 Billion JPY | 306.81% |
| 2019 Q3 | 5.25 Billion JPY | 3.32% |
| 2018 Q3 | 3.55 Billion JPY | -8.33% |
| 2018 FY | 9.79 Billion JPY | 5.49% |
| 2018 Q4 | -1.07 Billion JPY | -130.16% |
| 2018 Q2 | 3.87 Billion JPY | 12.7% |
| 2018 Q1 | 3.44 Billion JPY | 523.12% |
| 2017 Q3 | 4.45 Billion JPY | 32.12% |
| 2017 FY | 9.28 Billion JPY | -7.21% |
| 2017 Q1 | 2.27 Billion JPY | 42.45% |
| 2017 Q4 | -813 Million JPY | -118.25% |
| 2017 Q2 | 3.37 Billion JPY | 48.22% |
| 2016 Q2 | 2.81 Billion JPY | 105.24% |
| 2016 Q3 | 4.22 Billion JPY | 49.86% |
| 2016 Q4 | 1.59 Billion JPY | -62.18% |
| 2016 FY | 10.01 Billion JPY | 10.04% |
| 2016 Q1 | 1.37 Billion JPY | 6.35% |
| 2015 FY | 9.09 Billion JPY | 5.41% |
| 2015 Q4 | 1.29 Billion JPY | -56.0% |
| 2015 Q3 | 2.93 Billion JPY | -17.24% |
| 2015 Q2 | 3.54 Billion JPY | 166.94% |
| 2015 Q1 | 1.32 Billion JPY | -52.3% |
| 2014 Q4 | 2.78 Billion JPY | 22.7% |
| 2014 FY | 8.63 Billion JPY | -3.53% |
| 2014 Q1 | 648 Million JPY | -14.85% |
| 2014 Q2 | 2.93 Billion JPY | 352.16% |
| 2014 Q3 | 2.26 Billion JPY | -22.56% |
| 2013 Q4 | 761 Million JPY | -79.22% |
| 2013 FY | 8.94 Billion JPY | 10.63% |
| 2013 Q1 | 1.91 Billion JPY | 92.48% |
| 2013 Q2 | 2.6 Billion JPY | 35.7% |
| 2013 Q3 | 3.66 Billion JPY | 40.67% |
| 2012 Q1 | 1.74 Billion JPY | 49.36% |
| 2012 Q4 | 997 Million JPY | -72.62% |
| 2012 Q2 | 1.7 Billion JPY | -2.52% |
| 2012 Q3 | 3.64 Billion JPY | 113.98% |
| 2012 FY | 8.08 Billion JPY | -1.19% |
| 2011 Q2 | 2.09 Billion JPY | 5.18% |
| 2011 Q3 | 2.93 Billion JPY | 40.57% |
| 2011 Q4 | 1.16 Billion JPY | -60.21% |
| 2011 FY | 8.18 Billion JPY | 2.74% |
| 2011 Q1 | 1.98 Billion JPY | 48.51% |
| 2010 FY | 7.96 Billion JPY | 2.55% |
| 2010 Q1 | 1.31 Billion JPY | -38.33% |
| 2010 Q2 | 2.29 Billion JPY | 74.98% |
| 2010 Q3 | 3.02 Billion JPY | 31.69% |
| 2010 Q4 | 1.33 Billion JPY | -55.71% |
| 2009 Q2 | 1.25 Billion JPY | -31.67% |
| 2009 FY | 7.76 Billion JPY | 26.54% |
| 2009 Q1 | 1.84 Billion JPY | 29.28% |
| 2009 Q4 | 2.12 Billion JPY | -16.37% |
| 2009 Q3 | 2.54 Billion JPY | 102.07% |
| 2008 Q3 | 1.96 Billion JPY | 16.71% |
| 2008 Q2 | 1.68 Billion JPY | 0.0% |
| 2008 Q4 | 1.42 Billion JPY | -27.46% |
| 2008 FY | 6.13 Billion JPY | -18.42% |
| 2007 FY | 7.52 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Kitanotatsujin Corporation | 994.66 Million JPY | -3010.209% |
| Euglena Co., Ltd. | -2.67 Billion JPY | 1254.759% |
| BEAUTY GARAGE Inc. | 1.08 Billion JPY | -2752.093% |
| Axas Holdings Co.,Ltd. | 31.37 Million JPY | -98510.226% |
| C.I. Medical Co.,Ltd. | 2.08 Billion JPY | -1385.879% |
| Kao Corporation | 43.87 Billion JPY | 29.483% |
| Niitaka Co., Ltd. | 705.93 Million JPY | -4282.255% |
| Shiseido Company, Limited | 21.74 Billion JPY | -42.241% |
| Lion Corporation | 14.62 Billion JPY | -111.543% |
| Mandom Corporation | 2.6 Billion JPY | -1089.389% |
| Ivy Cosmetics Corporation | 160.31 Million JPY | -19197.491% |
| Milbon Co., Ltd. | 4 Billion JPY | -673.086% |
| Nippon Shikizai, Inc. | 398.11 Million JPY | -7670.658% |
| Fancl Corporation | 8.83 Billion JPY | -250.232% |
| KOSÉ Corporation | 11.66 Billion JPY | -165.249% |
| Cota Co., Ltd. | 1.34 Billion JPY | -2192.763% |
| HABA Laboratories,Inc. | -2.11 Billion JPY | 1560.191% |
| C'bon Cosmetics Co.,Ltd. | -26.34 Million JPY | 117513.086% |
| Pola Orbis Holdings Inc. | 9.66 Billion JPY | -220.083% |
| Noevir Holdings Co., Ltd. | 7.67 Billion JPY | -303.18% |
| Adjuvant Holdings Co.,Ltd. | -99.86 Million JPY | 31077.82% |
| Almado, Inc. | 695.45 Million JPY | -4348.304% |
| I-ne CO., LTD. | 3.95 Billion JPY | -682.398% |
| Premier Anti-Aging Co., Ltd. | -1.48 Billion JPY | 2186.042% |
| Liberta Co.,Ltd. | 111.33 Million JPY | -27686.66% |
| AXXZIA Inc. | 794.34 Million JPY | -3794.515% |
| S.T. Corporation | 1.27 Billion JPY | -2328.257% |
| Kobayashi Pharmaceutical Co., Ltd. | 20.33 Billion JPY | -52.109% |
| Earth Corporation | 4.1 Billion JPY | -654.169% |
| Sagami Rubber Industries Co., Ltd. | 40.95 Million JPY | -75434.72% |
| Asahi Eito Holdings Co.,Ltd. | -623.21 Million JPY | 5063.945% |
| Ya-Man Ltd. | 398.33 Million JPY | -7666.425% |
| MTG Co., Ltd. | 1.98 Billion JPY | -1459.274% |
| TRANSACTION CO.,Ltd. | 3.76 Billion JPY | -721.979% |
| SHOBIDO Corporation | 475.43 Million JPY | -6406.883% |
| Artnature Inc. | 1.46 Billion JPY | -2016.005% |
| Pigeon Corporation | 7.42 Billion JPY | -316.759% |
| Unicharm Corporation | 86.05 Billion JPY | 64.05% |
| Paltac Corporation | 20.63 Billion JPY | -49.898% |
| CB GROUP MANAGEMENT Co., Ltd. | 2.05 Billion JPY | -1403.938% |